Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06831136
Title Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma (PANCARDINAL-2)
Acronym PANCARDINAL-2
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors The University of Texas Health Science Center, Houston
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.